Articles about 'EMBO'

Cambridge scientists elected as Members of the European Molecular Biology Organisation

09 July 2024

Five Cambridge researchers join the community of over 2,100 leading life scientists today as the European Molecular Biology Organisation (EMBO) announces its newest Members in its 60th anniversary year.

Cambridge researchers elected as members of European Molecular Biology Organisation

06 July 2022

Five Cambridge researchers join the community of more than 1,900 leading life scientists in Europe and beyond today as the European Molecular Biology Organisation announces its newly-elected Members.

Eight Cambridge researchers elected as members of the European Molecular Biology Organisation

07 July 2020

Eight Cambridge researchers - six from the University of Cambridge and two from the MRC Laboratory of Molecular Biology - are among the 63 scientists from around the world elected this year as Members and Associate Members of the European Molecular Biology Organisation (EMBO).

Cambridge scientists recognised by major European research organisation

18 June 2019

Researchers from the Cambridge Biomedical Campus have featured prominently in this year’s election to the prestigious European Molecular Biology Organisation (EMBO).

Crystal structure of parallel quadruplexes from human telomeric DNA.

Quadruple helix form of DNA may aid in the development of targeted cancer therapies

12 September 2016

Researchers have identified the role that a four-stranded version of DNA may play in the role of cancer progression, and suggest that it may be used to develop new targeted cancer therapies.

Cancer-associated DNA changes exist in a quarter of normal skin cells

21 May 2015

Normal skin contains an unexpectedly high number of cancer-associated mutations, according to a study published in Science. The findings illuminate the first steps cells take towards becoming a cancer and demonstrate the value of analysing normal tissue to learn more about the origins of the disease.

Cell nucleus before and after treatment with Remodelin

'Remodelling' damaged nuclei could lead to new treatments for accelerated ageing disease

01 May 2014

Scientists at the University of Cambridge have identified a key chemical that can repair the damage to cells which causes a rare but devastating disease involving accelerated ageing. As well as offering a promising new way of treating the condition, known as Hutchinson-Gilford Progeria Syndrome (HGPS), the discovery could help in the development of drugs against cancer and other genetic diseases and might also suggest ways to alleviate diseases that we associate with normal ageing.

Articles about 'EMBO'

Cambridge scientists elected as Members of the European Molecular Biology Organisation

Cambridge researchers elected as members of European Molecular Biology Organisation

Eight Cambridge researchers elected as members of the European Molecular Biology Organisation

Cambridge scientists recognised by major European research organisation

Quadruple helix form of DNA may aid in the development of targeted cancer therapies

Cancer-associated DNA changes exist in a quarter of normal skin cells

'Remodelling' damaged nuclei could lead to new treatments for accelerated ageing disease

Connect with us

Study at Cambridge

About the University

Research at Cambridge